ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 24 filers reported holding ONCTERNAL THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,412 | -13.0% | 84,706 | 0.0% | 0.00% | – |
Q2 2023 | $29,224 | -56.1% | 84,706 | 0.0% | 0.00% | – |
Q1 2023 | $66,494 | -18.8% | 84,706 | +3.4% | 0.00% | – |
Q4 2022 | $81,902 | +12.2% | 81,902 | 0.0% | 0.00% | – |
Q3 2022 | $73,000 | -19.8% | 81,902 | 0.0% | 0.00% | – |
Q2 2022 | $91,000 | -82.5% | 81,902 | -78.1% | 0.00% | – |
Q1 2022 | $519,000 | -42.3% | 373,545 | -5.8% | 0.00% | – |
Q4 2021 | $900,000 | -62.1% | 396,576 | -30.3% | 0.00% | – |
Q3 2021 | $2,373,000 | -15.2% | 569,032 | -3.5% | 0.00% | – |
Q2 2021 | $2,800,000 | +298.3% | 589,645 | +598.1% | 0.00% | – |
Q1 2021 | $703,000 | +224.0% | 84,465 | +90.5% | 0.00% | – |
Q4 2020 | $217,000 | +734.6% | 44,331 | +192.3% | 0.00% | – |
Q3 2020 | $26,000 | -35.0% | 15,165 | +9.4% | 0.00% | – |
Q2 2020 | $40,000 | 0.0% | 13,861 | +2.0% | 0.00% | – |
Q1 2020 | $40,000 | -25.9% | 13,584 | 0.0% | 0.00% | – |
Q4 2019 | $54,000 | -26.0% | 13,584 | +22.5% | 0.00% | – |
Q2 2019 | $73,000 | – | 11,091 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 210,000 | $187,000 | 0.26% |
Quantum Private Wealth, LLC | 461,356 | $411,000 | 0.26% |
Beta Wealth Group, Inc. | 32,000 | $29,000 | 0.02% |
BRIGHTON JONES LLC | 334,053 | $298,000 | 0.02% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 53,554 | $48,000 | 0.01% |
AXXCESS WEALTH MANAGEMENT, LLC | 87,863 | $78,000 | 0.01% |
Balboa Wealth Partners | 17,500 | $16 | 0.01% |
IPG Investment Advisors LLC | 23,691 | $21,123,000 | 0.01% |
DOWLING & YAHNKE LLC | 150,464 | $134,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 35,012 | $31,000 | 0.00% |